Showing results (81-90 of 171) with videos related to
Sort By:
Pageof 18
Emerging Topics in Life Sciences|February 2, 2021
Alternative strategies for the study and treatment of clinical bacterial biofilmsCorrie R Belanger, Sarah C Mansour, Daniel Pletzer, et al.International Journal of Pharmaceutics|January 9, 2022
Optimization of methionine in inhalable High-dose Spray-dried amorphous composite particles using response surface Method, infrared and low frequency Raman spectroscopyBishal Raj Adhikari, Kārlis Bērziņš, Sara J Fraser-Miller, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|June 21, 2019
Crystalline adduct of moxifloxacin with trans-cinnamic acid to reduce the aqueous solubility and dissolution rate for improved residence time in the lungsBasanth Babu Eedara, Ian G Tucker, Zoran D Zujovic, et al.Pharmaceutics|October 5, 2019
Inhalable Dry Powder of Bedaquiline for Pulmonary Tuberculosis: In Vitro Physicochemical Characterization, Antimicrobial Activity and Safety StudiesMohammad A M Momin, Bhamini Rangnekar, Shubhra Sinha, et al.Journal of Medicinal Chemistry|August 14, 2020
Cyclic Derivative of Host-Defense Peptide IDR-1018 Improves Proteolytic Stability, Suppresses Inflammation, and Enhances In Vivo ActivityHashem Etayash, Daniel Pletzer, Prashant Kumar, et al.Genome Announcements|June 11, 2016
Draft Genome Sequence of Dietzia maris DSM 43672, a Gram-Positive Bacterium of the Mycolata GroupSonalli Ganguly, Guadalupe Jimenez-Galisteo, Daniel Pletzer, et al.Mbio|March 2, 2017
New Mouse Model for Chronic Infections by Gram-Negative Bacteria Enabling the Study of Anti-Infective Efficacy and Host-Microbe InteractionsDaniel Pletzer, Sarah C Mansour, Kelli Wuerth, et al.International Journal of Pharmaceutics|March 10, 2024
Triple combination dry powder formulation of pretomanid, moxifloxacin, and pyrazinamide for treatment of multidrug-resistant tuberculosisClaire Fan, Basanth Babu Eedara, Shubhra Sinha, et al.International Journal of Pharmaceutics|February 20, 2018
Co-spray drying of hygroscopic kanamycin with the hydrophobic drug rifampicin to improve the aerosolization of kanamycin powder for treating respiratory infectionsMohammad A M Momin, Ian G Tucker, Colin S Doyle, et al.BMJ Open Respiratory Research|January 26, 2021
Is the use of two versus one long-acting bronchodilator by patients with COPD associated with a higher risk of acute coronary syndrome in real-world clinical practice?Lianne Parkin, Sheila Williams, David Barson, et al.Pageof 18